"The voice for cancer physicians and their patients in Massachusetts."
The U.S. Food and Drug Administration approved Herzuma (trastuzumab-pkrb; Celltrion) as a biosimilar to Herceptin (trastuzumab; Genentech) for patients with HER2-overexpressing breast cancer. Read full press release.
Massachusetts Society of Clinical Oncologists (c) 860 Winter Street, Waltham, MA. 02451
Waltham, MA. 02451